&mu;g/mL), and PAI-1 (7.3&plusmn; 2.4 ng/mL) in the dialysate (4-hr dwell time), and a 2.4-times higher ratio between FM and FbDP. These results can be interpreted as an intraperitoneal imbalance between coagulation and fibrinolysis during peritonitis. .Conclusion: Our study demonstrates a high intraperitoneal fibrin formation, not only during peritonitis but also in clinically stable CAPD patients. The remarkably high levels of coagulation (F1+2, TAT, FM) and fibrinolysis (FbDP, DD, t-PA, PAI-1) related antigens in the dialysate of patients without peritonitis cannot be explained by transport from plasma into the peritoneal cavity and may reflect a high rate of intraperitoneal fibrin turnover. The balance between peritoneal generation and degradation of fibrin is obviously disturbed in CAPD patients with peritonitis, who had significantly higher levels of coagulation markers in the dialysate and a higher ratio between FM and FbDP .
KEY WORDS: Peritonitis; intraperitoneal fibrinolysis; intraperitoneal coagulation.
T he mesothelial fibrinolytic activity of the peritoneum is a key factor in the prevention and re moval of fibrin depositions in the peritoneal cavity and thus in the prevention of peritoneal adhesions (1, 2) . During regular continuous ambulatory peritoneal dialysis (CAPD), peritoneal fibrin deposition leading to adhesions can rarely be observed, indicating that procoagulant (fibrin-forming) and fibrinolytic (fibrin-dissolving) activities of the peritoneum are balanced under normal conditions. This balance is obviously disturbed during peritonitis (3). Bacterial infection causes an inflammatory response of the serosal surfaces with outpouring of serofibrinous exudate resulting in peritoneal fibrin deposition (46). Thereby, the peritoneal fibrinolytic capacity determines whether fibrin deposits are lysed or become organized with proliferation of fibroblasts and formation of collagen, resulting in fibrosis (7, 8) . Peritoneal biopsies from CAPD patients with peritonitis have highlighted a possible causal relationship between prolonged fibrin exudation and subsequent development of serosal fibrosis (9, 10) . If fibrous adhesions are formed as a sequel of increased pro coagulant and/or decreased fibrinolytic activity of the peritoneum, efforts to artificially modulate the intraperitoneal hemostatic system may be warranted. Therefore, detailed knowledge of the fibrinolytic system in the peritoneal cavity is needed. The present study is aimed at gaining insight into the generation and degradation of fibrin in the peritoneal cavity of CAPD patients with and without peritonitis. The prothrombin fragment (Fl+2), which is generated during enzymatic conversion of prothrombin into thrombin, the complexes between thrombin and its inhibitor antithrombin III (TAT), and fibrin monomer (FM), the product of the coagulation cascade, were measured in the dialysis effluent as markers for ongoing coagulation (11, 12) . Moreover, fibrin degradation products (FbDP), D -dimer (DD), tissue-type plasminogen activator (t-PA), and plasminogen activator inhibitor type 1 (PAl-l) were determined as fibrinolytic parameters (13) .
PATIENTS AND METHODS

PATIENTS
The study population comprised 16 patients (6 female, 10 male, aged 24 -58 years, mean age 42) receiving CAPD for treatment of end-stage renal failure of different etiologies. Eleven patients had no clinically overt dialysis problems during the preceding six months, and 5 patients presented with the signs of acute peritonitis at the time of sample collection. The clinical diagnosis of peritonitis was based on abdominal pain, cloudy dialysate, and more than lOO cellslmm3. Cultures of the dialysate revealed Staphylocaccus epidermidis in three cases and Escherichia coli in one case. The dialysate culture of one patient was negative. The daily CAPD regime for all patients consisted of four to six exchanges over 24 hours, using 2 L of glucose-based (1.36% -3.86%) dialysis solution. The mean duration on CAPD was 32 months (range: 7 117 months).
In patients without peritonitis a peritoneal equilibration test (PET) was performed, as described by Twardowski (14) . Two liters of2.27% glucose-based dialysis solution were infused into the peritoneal cavity within ten minutes. Blood and dialysate samples were taken 0,2, and 4 hours after the completion of the infusion. In patients presenting with acute peritonitis, dialysate samples were drawn after a four-hour dwell time at admission to the hospital, prior to commencing therapy. Dialysate and blood samples were centrifuged to remove cells and debris, and stored at -20°C until analysis. ASSAY S Prothrombin fragments (Fl+2) and TAT were measured by an enzyme-Iinked immunosorbent assay (ELISA) according to the manufacturer's descriptions (Behring, Marburg, Germany). Fibrin monomer and DD were assayed by an ELISA developed by Boehringer Mannheim (Mannheim, Germany), Assay of t-PA antigen and FbDP was performed with an ELISA from Organon-Teknika (Turnhout, Belgium). PAI-l and t -PA antigen were measured by ELISA ( Coelisa P AI -1, Coelisa t P A) obtained from Chromogenix (M&ouml;lndal, Sweden).
STATISTIC S
Data are expressed as mean &plusmn; SEM. Statistical analysis was carried out by Mann-Whitney U-test, and p < 0.05 was considered significant.
RESULTS
Measurements of coagulation and fibrinolysis related antigens during a peritoneal equilibration test comparing dialysate and plasma levels 0,2, and 4 hours after infusion of the dialysate are shown in Table 1 . Fl+2, TAT, and FM increased in the dialysate during the four-hour dwell time, indicating a high rate of intraperitoneal fibrin generation. The parallel increments of the raised fibrin fragments (FbDP, DD) and of t-PA in the dialysate reflect peritoneal fibrin-dissolving activity, which obviously counteracts fibrin formation. Compared to the plasma concentrations, which exceeded normal ranges, the dialysate levels (after four-hour dwell time) of the determined antigens were significantly (p < 0.05) lower, with the exception of FM and FbDP. After a four-hour dwell time the amount of FM, the end product of the coagulation cascade, was about fourfold higher in the dialysate, and the ratio between FM and its degradation products, FbDP or DD, was about 1.3, sixfold higher in dialysate than in plasma.
To exclude the possibility that the high concentrations of coagulation and fibrinolysis -related antigens in the dialysate are mainly the result of transport from plasma into the peritoneal cavity, we compared their dialysate-toplasma (D/P) ratio with the DIP ratio of serum proteins of intravascular origin (&beta;2-microglobulin, albumin, and IgG). The D/P quotients (after four-hour dwell time) of antigens related to coagulation and fibrinolysis were significantly higher, regardless of their molecular weight, and they did not correlate with the D/P ratio of the marker proteins used (Figure 1 ). These findings point to local intraperitoneal production. Figure 2 shows the changes in coagulation and fibrinolysis related antigens in the peritoneal dialysate of stable CAPD patients during the four-hour dwell time. The concentrations of Fl+2 showed a lag phase after a marked increase during the first hour. FM, the prod uct of the coagulation cascade, rose continuously, while the concentrations of the initiator offibrinoly sis, t-PA, remained unchanged. In contrast to this, the concentration of its inhibitor, PAI-l, increased during the dwell time (15) .
In comparison with clinically stable patients the concentrations of coagulation-related antigens were significantly higher in the dialysate of patients with an acute episode of bacterial peritonitis. As shown in Table 2 , the mean concentration of the prothrombin fragment Fl +2, which is generated during enzymatic conversion of prothrombin into thrombin, was 13 times higher in the peritonitis group. Also, the mean concentration of t he complexes formed between thrombin and its inhibitor, TAT, exceeded by ninefold that in patients without peritonitis. The markedly stimulated thrombin formation, as shown by elevated levels ofFl+2 and TAT, resulted in ahigher fibrin generation, documented by a fortyfold higher concentration ofFM. Time parallel with the increase in Fl+2, TAT, and FM in the dialysate of patients with peritonitis, the concentrations of FbDP were also significantly enhanced (Table 2) . However, the relative increase in the f ibrinolytic activity, as indicated by the extent ofFbDP formation, does not keep pace with the augmentation in fibrin generation, as indicated by FM formation: the ratio between FM and FbDP in the dialysate of the peritonitis group was 2.4 times higher than that in stable patients. This imbalance between coagulation and fibrinolysis during peritonitis is also reflected by significantly elevated P AI -1 levels in the effluent, while the concentration of t PA did not differ significantly between the dialysate of patients with and without peritonitis ( Table 2) .
DISCUSSION
The main results of our study demonstrate an accelerated intraperitoneal fibrin turnover, not only during the phase of acute peritonitis but also in clinically stable CAPD patients. The remarkably high dialysate levels of Fl+2, TAT, and FM after four-hour dwell time in patients without peritonitis point to a hypercoagulatory state with permanent intraperitoneal fibrin formation. This corresponds to the clinical observation of visible fibrin clots in the dialysis effluent of several patients on regular CAPD (16) . Previously, morphological studies by Dobbie (17) have shown that physical and chemical irritation of the peritoneum during CAPD can result in a nonbacterial inflammatory state with peritoneal serofibrinous exudation, and the presence of a hyperosmolar glucose solution with unphysiological pH may be sufficient for such irritation (18) . The elevated concentrations of the investigated markers in plasma compared to normal range values confirm earlier studies which describe an activated coagulation system in patients with chronic uremia (19) . Whereas plasma levels of all parameters showed no significant differences at the beginning and the end of the dwell time, the increase in dialysate is significant for all parameters except t-PA and PAI-l. With the exception of soluble fibrin (FM), the mean concentrations of all other coagulation and fibrinolysis related antigens were higher in plasma than in dialysate. However, compared with the D/P ratio of other serum proteins, which are not produced intraperitoneally, the high concentrations of coagulation markers in dialysis effluent could not be attributed to diffusion from the intravascular system into the peritoneal cavity.
The rare occurrence of peritoneal fibrosis in CAPD patients without peritonitis, despite high fibrin generation, suggests that peritoneal coagulant activity is usually balanced by an active fibrinolytic system. The presence of an augmented fibrinolytic activity is sub stantiated by the detection of high levels of t PA, which is produced intraperitoneally by mesothelial cells (20) , and fibrin degradation products (DD, FbDP) in the dialysate. Thereby, the higher FM/DD ratio in the dialysate compared to plasma suggests that intraperitoneal coagulation predominates over fibrinolysis. During bacterial inflammation the balance between peritoneal coagulant and fibrinolytic activity is obviously disturbed (3) . Although the increase in coagulation markers (TAT, Fl+2, FM) is accompanied by significantly higher levels ofFbDP, the ratio between FM and FbDP is elevated compared with clinically stable patients. This can be interpreted as an increase in fibrin generation during peritonitis which cannot be compensated anymo re by fibrinolytic activity. A similar assumption was made bySuzukietal. (21) , who discussed the possibility of using fibrin degradation products to assess the clinical course of peritonitis. The significantly higher dialysate levels ofP AI -1 in patients with peritonitis in the presence of comparable levels oft-PA in both groups indicate that fibrinolytic activity is not sufficient to counteract fibrin formation. These findings confirm the results from in vitra studies, where inflammatory mediators decreased the fibrinolytic activity of the mesothelium by increasing PAI-l and decreasing t-PA production in peritoneal mesothelial cells (20) . As a consequence, there are fibrin deposits which are organized with a proliferation offibroblasts, resulting in loss of mesothelial cells and peritoneal fibrosis (7, 8) . To minimize the risk of permanent me sothelial injuries and peritoneal fibrosis, treatment of peritonitis should include the intraperitoneal application of heparin to inhibit intraperitoneal fibrin forma tion (16) . Whether or not the intraperitoneal application oft-PA has an additional effect on the prevention of peritoneal fibrin deposition should be confirmed in clinical studies (22) .
In summary, our results indicate a plasma-independent intraperitoneal hemostatic system. Thereby, long-term CAPD coexists permanent hypercoagulopathy and hyperfibrinolysis in the peritoneal cavity. During peritonitis, procoagulant activity predominates over fibrinolysis with the risk ofperitoneal fibrin deposits resulting in fibrosis.
